MFNG
Beta-1,3-N-acetylglucosaminyltransferase manic fringe
Also known as: MFNG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00587
- Gene
- MFNG
- Ensembl
- ENSG00000100060
- Chromosome
- 22
- Canonical length
- 321 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene is a member of the glycosyltransferase 31 gene family. Members of this gene family, which also includes the LFNG (GeneID: 3955) and RFNG (GeneID: 5986) genes, encode evolutionarily conserved glycosyltransferases that act in the Notch signaling pathway to define boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, these proteins have a fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling. The protein encoded by this gene may control Notch signaling in claudin-low breast cancer. [provided by RefSeq, May 2018]
Canonical amino-acid sequenceUniProt
321 residues, UniProt reviewed canonical sequence.
>O00587|MFNG
1 MQCRLPRGLA GALLTLLCMG LLCLRYHLNL SPQRVQGTPE LSQPNPGPPK LQLHDVFIAV
61 KTTRAFHRLR LELLLDTWVS RTREQTFVFT DSPDKGLQER LGSHLVVTNC SAEHSHPALS
121 CKMAAEFDTF LASGLRWFCH VDDDNYVNPR ALLQLLRAFP LARDVYVGRP SLNRPIHASE
181 PQPHNRTRLV QFWFATGGAG FCINRKLALK MAPWASGSRF MDTSALIRLP DDCTMGYIIE
241 CKLGGRLQPS PLFHSHLETL QLLRTAQLPE QVTLSYGVFE GKLNVIKLQG PFSPEEDPSR
301 FRSLHCLLYP DTPWCPQLGA RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MFNG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 65 nTPM
- spleen: 58 nTPM
- thymus: 47 nTPM
- tonsil: 40 nTPM
- bone marrow: 38 nTPM
- appendix: 35 nTPM
Single-cell type
- megakaryocytes: 173 nCPM
- platelets: 138 nCPM
- megakaryocyte progenitors: 66 nCPM
- lymphatic endothelial cells: 47 nCPM
- nk-cells: 42 nCPM
- vascular endothelial cells: 40 nCPM
Immune cell
- eosinophil: 388 nTPM
- total PBMC: 314 nTPM
- T-reg: 285 nTPM
- naive CD4 T-cell: 244 nTPM
- memory CD4 T-cell: 223 nTPM
- non-classical monocyte: 220 nTPM
Brain region
- pons: 36 nTPM
- medulla oblongata: 23 nTPM
- thalamus: 17 nTPM
- midbrain: 16 nTPM
- white matter: 15 nTPM
- spinal cord: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.56
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blastocyst formation
- marginal zone B cell differentiation
- pattern specification process
- positive regulation of Notch signaling pathway
- regulation of Notch signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MFNG as an antibody target. Whether an autoantibody or antibody against MFNG could matter depends on whether native MFNG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MFNG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MFNG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...